-+ 0.00%
-+ 0.00%
-+ 0.00%

EXELIXIS SHARES FALL 3% AFTER US FDA EXTENDS REVIEW OF CO'S CANCER DRUG

Reuters·09/11/2026 13:32:20

Please log in to view news